Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Illumina
MedTech
Illumina sales flat in Q3 amid China headwinds
Illumina’s revenue was flat for the third quarter as the sequencing giant continues to deal with headwinds from a China sales ban.
Ben Adams
Oct 31, 2025 8:55am
Illumina launches AI informatics business for multi-omics data
Oct 1, 2025 11:30am
Illumina begins rolling out protein analysis platform
Sep 3, 2025 2:30pm
Illumina picks up proteomics developer SomaLogic for $425M
Jun 23, 2025 11:00am
PacBio expands reach in China with clinical distribution deal
May 22, 2025 12:00pm
Illumina, Tempus team up to expand DNA profiling beyond cancer
Apr 15, 2025 11:30am
